Duopharma eyes M&A prospects in Philippines, Indonesia

Duopharma group managing director Leonard Ariff Abdul Shatar.

KUALA LUMPUR: Duopharma Biotech Bhd is actively evaluating two potential mergers and acquisitions (M&A) proposals from the Philippines and Indonesia, according to group managing director Leonard Ariff Abdul Shatar.

However, he said the company remains open to M&A within ASEAN to facilitate more seamless business integration.